about
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapyRole of viruses and bacteria-virus interactions in autoimmunityImmunomodulatory effects of transforming growth factor-β in the liver.Anti-Self Phosphatidylserine Antibodies Recognize Uninfected Erythrocytes Promoting Malarial Anemia.Complexities in the relationship between infection and autoimmunity.Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.Pathogen infection as a possible cause for autoimmune hepatitis.ANA testing in the presence of acute and chronic infections.Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta.Hepatitis B carrier state among SLE patients: case-control study.Is there an association between pemphigus and hepatitis viruses? A population-based large-scale study.Environmental peer pressure: CD4+ T cell help in tolerance and transplantation.Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.Normal vitamin D levels are associated with spontaneous hepatitis B surface antigen seroclearance.Adult idiopathic cholestasis: a condition more common in the Canadian Inuit?Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy.A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity.
P2860
Q26766115-F9A8D52A-F95A-42F4-B839-E62024C7B493Q26829755-B6CF007A-35CE-4865-9D85-177852C9750BQ34750481-7DB94973-5E63-47A4-9261-C3F17FE02A72Q36883456-FF2BBFBD-8BF3-434B-9318-7ECD553CE9BCQ37588412-ECFBEDD8-4DD2-4BD2-B658-497DDB1AA47BQ37654478-691DDBE3-EF8A-4A7D-B54C-118AD1BD13B3Q38218770-EAE0F607-1DDE-4494-B383-250C97ADE25AQ38799673-7C5498E8-5D65-4CC6-B0D8-D3CB3EE6B11FQ38937496-B45A5E3A-3276-4B9D-AC49-3D5E024C053BQ39595587-72F4033B-DFEC-4A37-ABB5-31D9D2E7CD9BQ40041941-C02B64EF-8731-4567-8913-9F1ECBFE5C04Q41996562-301C2AD7-4386-4B60-B2BB-91B944AA9434Q42205181-86D5F5BB-A5C9-44DB-94F5-75D34D9C2252Q42206002-108C9CD2-108F-41FC-9174-6FEDE888E56FQ42214549-15BD1284-C343-40FC-AEC3-4ABED3F12AE1Q42287803-6942E6F7-AC9D-4B6C-B980-78AC79164123Q42682787-4AF710F6-7C74-4CF3-B4DB-D880D546593EQ54940587-822FBEAD-5C2F-454A-904F-01F69914BBE9Q55512501-9F19280D-F3FE-4880-A38C-639604975057
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Autoimmune manifestations in viral hepatitis.
@en
type
label
Autoimmune manifestations in viral hepatitis.
@en
prefLabel
Autoimmune manifestations in viral hepatitis.
@en
P2860
P1476
Autoimmune manifestations in viral hepatitis.
@en
P2093
Diego Vergani
Giorgina Mieli-Vergani
P2860
P2888
P356
10.1007/S00281-012-0328-6
P577
2012-07-28T00:00:00Z
P5875
P6179
1018202021